Clinical trial to evaluate the effect of advanced formulation for Lepidium meyenii on late-onset hypogonadism

Not Applicable

Completed

• Conditions: Diseases of the genitourinary system

• Registration Number: KCT0006415
• Lead Sponsor: The Catholic University of Korea, Seoul St. Mary's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-05-14
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 88

Inclusion Criteria

1. men aged over 40 years
2. complaining of symptoms related to late onset hypogonadism with total scores on the Aging Males’ Symptoms scale (AMS) questionnaire =27

Exclusion Criteria

1. Subjects who had taken testosterone replacement therapy (TRT) within 6 months before randomization
2. Total serum Testosterone < 2.0 ng/mL
3. Subject who has taken PDE5 inhibitor
4. history or diagnosis of prostate cancer
5. prostate specific antigen =4.0ng/mL
6. severe obstructive sleep apnea
7.

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The change of Aging males' symptoms Korean version (AMS) score from baseline

Secondary Outcome Measures

Name	Time	Method
The change of International Index of Erectile Function (IIEF-5) score from baseline;The change of Androgen Deficiency in Aging Males (ADAM) score from baseline;The change of International Prostate Symptom Score (IPSS) from baseline